Scanning Medical Journals
No new significant updates or guidelines matching this topic were found today. We will check again soon.
Anticoagulation Bridging: Assessment of thrombotic vs. bleeding risk. The modern standard (BRIDGE trial) favors holding therapy without heparin coverage for most patients.
1. Primary Condition
2. Risk Granularity
Consensus Strategy
Thrombotic Risk
Low Risk
The risk of major bleeding from bridging outperforms the thrombotic benefit. Hold VKA as per surgery type.
Verified
Last Review: 2026
Last Comprehensive Review: 2026